SIA "Orthos Pharma"Active
Key figures
Ratios
2025Balance sheet structure
Summary of financial statements2015–2025
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||||
| Total current assets | 4177 | 161 755 | 3688 | 363 310 | 4 788 012 | 4 716 662 | 2 832 317 | 6 005 852 | 6 797 559 | 8 343 399 | 12 502 397 |
| Total non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4531 | 13 292 | 25 776 |
| Total assets | 4177 | 161 755 | 3688 | 363 310 | 4 788 012 | 4 716 662 | 2 832 317 | 6 005 852 | 6 802 090 | 8 356 691 | 12 528 173 |
| Balance sheet — liabilities and equity | |||||||||||
| Current liabilities | 2170 | 161 312 | 13 028 | 382 027 | 3 695 653 | 3 326 289 | 1 613 986 | 2 960 156 | 3 148 798 | 3 553 774 | 6 887 040 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 2170 | 161 312 | 13 028 | 382 027 | 3 695 653 | 3 326 289 | 1 613 986 | 2 960 156 | 3 148 798 | 3 553 774 | 6 887 040 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | -993 | -1564 | -9783 | -9377 | 1 111 076 | 298 014 | -166 239 | 1 827 365 | 621 407 | 1 149 625 | 838 216 |
| Total equity | 2007 | 443 | -9340 | -18 717 | 1 092 359 | 1 390 373 | 1 218 331 | 3 045 696 | 3 653 292 | 4 802 917 | 5 641 133 |
| Income statement | |||||||||||
| Sales revenue | 28 302 | 162 306 | 15 862 | 38 709 | 7 856 129 | 10 498 946 | 10 907 225 | 10 879 951 | 15 560 557 | 20 305 642 | 29 407 217 |
| Operating profit | -993 | -1557 | -9734 | -9207 | 1 112 465 | 298 014 | -166 239 | 1 827 365 | 621 407 | 1 149 625 | 838 216 |
| Profit before income tax | -993 | -1564 | -9783 | -9377 | 1 111 076 | 298 014 | -166 239 | 1 827 365 | 621 407 | 1 149 625 | 838 216 |
| Profit for the reporting year | -993 | -1564 | -9783 | -9377 | 1 111 076 | 298 014 | -166 239 | 1 827 365 | 621 407 | 1 149 625 | 838 216 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||||
| Employees | 2 | 2 | 2 | 2 | 5 | 16 | 17 | 18 | 22 | 42 | 46 |
| Calculated dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: SIA "Orthos Pharma"
Overview
SIA "Orthos Pharma" (reg. no. 50103850761) is a limited liability company. The company was registered in 2014 and has been in the register for 11 years. Registered address: Rīga, Ozolciema iela 18 - 338.
Financial results
Revenue in 2025 was 29 407 217 €, up 44,8% on the previous year (20 305 642 €). From 2015 to 2025, revenue grew by an average of 100% per year. This is the company's highest revenue among the published years (2015–2025). Net profit for 2025 was 838 216 € (2,9% of revenue). The company was profitable in 6 of the 11 published years. In 2025 the company had 46 employees (42 a year earlier). Revenue per employee was 639 287 €. At the end of 2025, total assets were 12 528 173 € and equity 5 641 133 € (45,0% of assets).
Management and owners
The board has 2 members. The sole owner of the company is a private individual.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.